Index
1 Market Overview of POC Infectious Diseases
1.1 POC Infectious Diseases Market Overview
1.1.1 POC Infectious Diseases Product Scope
1.1.2 POC Infectious Diseases Market Status and Outlook
1.2 Global POC Infectious Diseases Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global POC Infectious Diseases Market Size by Region (2018-2029)
1.4 Global POC Infectious Diseases Historic Market Size by Region (2018-2023)
1.5 Global POC Infectious Diseases Market Size Forecast by Region (2024-2029)
1.6 Key Regions, POC Infectious Diseases Market Size (2018-2029)
1.6.1 North America POC Infectious Diseases Market Size (2018-2029)
1.6.2 Europe POC Infectious Diseases Market Size (2018-2029)
1.6.3 Asia-Pacific POC Infectious Diseases Market Size (2018-2029)
1.6.4 Latin America POC Infectious Diseases Market Size (2018-2029)
1.6.5 Middle East & Africa POC Infectious Diseases Market Size (2018-2029)
2 POC Infectious Diseases Market by Type
2.1 Introduction
2.1.1 Flu
2.1.2 Adenovirus
2.1.3 Malaria
2.1.4 Streptococcal Bacteremia
2.1.5 Tuberculosis (TB)
2.1.6 Occult Blood
2.1.7 HIV
2.2 Global POC Infectious Diseases Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global POC Infectious Diseases Historic Market Size by Type (2018-2023)
2.2.2 Global POC Infectious Diseases Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.2 Europe POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa POC Infectious Diseases Revenue Breakdown by Type (2018-2029)
3 POC Infectious Diseases Market Overview by Application
3.1 Introduction
3.1.1 Hospital& Clinics
3.1.2 Clinical Diagnostic Laboratories
3.1.3 Homecare Settings
3.2 Global POC Infectious Diseases Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global POC Infectious Diseases Historic Market Size by Application (2018-2023)
3.2.2 Global POC Infectious Diseases Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.2 Europe POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa POC Infectious Diseases Revenue Breakdown by Application (2018-2029)
4 POC Infectious Diseases Competition Analysis by Players
4.1 Global POC Infectious Diseases Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2022)
4.3 Date of Key Players Enter into POC Infectious Diseases Market
4.4 Global Top Players POC Infectious Diseases Headquarters and Area Served
4.5 Key Players POC Infectious Diseases Product Solution and Service
4.6 Competitive Status
4.6.1 POC Infectious Diseases Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott POC Infectious Diseases Products, Services and Solutions
5.1.4 Abbott POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Meridian Bioscience
5.2.1 Meridian Bioscience Profile
5.2.2 Meridian Bioscience Main Business
5.2.3 Meridian Bioscience POC Infectious Diseases Products, Services and Solutions
5.2.4 Meridian Bioscience POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.2.5 Meridian Bioscience Recent Developments
5.3 Orasure Technologies
5.3.1 Orasure Technologies Profile
5.3.2 Orasure Technologies Main Business
5.3.3 Orasure Technologies POC Infectious Diseases Products, Services and Solutions
5.3.4 Orasure Technologies POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.3.5 Trinity Biotech Recent Developments
5.4 Trinity Biotech
5.4.1 Trinity Biotech Profile
5.4.2 Trinity Biotech Main Business
5.4.3 Trinity Biotech POC Infectious Diseases Products, Services and Solutions
5.4.4 Trinity Biotech POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.4.5 Trinity Biotech Recent Developments
5.5 Beckman Coulter/ Danaher
5.5.1 Beckman Coulter/ Danaher Profile
5.5.2 Beckman Coulter/ Danaher Main Business
5.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Products, Services and Solutions
5.5.4 Beckman Coulter/ Danaher POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.5.5 Beckman Coulter/ Danaher Recent Developments
5.6 Becton Dickinson
5.6.1 Becton Dickinson Profile
5.6.2 Becton Dickinson Main Business
5.6.3 Becton Dickinson POC Infectious Diseases Products, Services and Solutions
5.6.4 Becton Dickinson POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.6.5 Becton Dickinson Recent Developments
5.7 Biomerieux
5.7.1 Biomerieux Profile
5.7.2 Biomerieux Main Business
5.7.3 Biomerieux POC Infectious Diseases Products, Services and Solutions
5.7.4 Biomerieux POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.7.5 Biomerieux Recent Developments
5.8 Bio-Rad
5.8.1 Bio-Rad Profile
5.8.2 Bio-Rad Main Business
5.8.3 Bio-Rad POC Infectious Diseases Products, Services and Solutions
5.8.4 Bio-Rad POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.8.5 Bio-Rad Recent Developments
5.9 Cepheid
5.9.1 Cepheid Profile
5.9.2 Cepheid Main Business
5.9.3 Cepheid POC Infectious Diseases Products, Services and Solutions
5.9.4 Cepheid POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.9.5 Cepheid Recent Developments
5.10 Diamedix
5.10.1 Diamedix Profile
5.10.2 Diamedix Main Business
5.10.3 Diamedix POC Infectious Diseases Products, Services and Solutions
5.10.4 Diamedix POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.10.5 Diamedix Recent Developments
5.11 Diasorin
5.11.1 Diasorin Profile
5.11.2 Diasorin Main Business
5.11.3 Diasorin POC Infectious Diseases Products, Services and Solutions
5.11.4 Diasorin POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.11.5 Diasorin Recent Developments
5.12 Eiken Chemical
5.12.1 Eiken Chemical Profile
5.12.2 Eiken Chemical Main Business
5.12.3 Eiken Chemical POC Infectious Diseases Products, Services and Solutions
5.12.4 Eiken Chemical POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.12.5 Eiken Chemical Recent Developments
5.13 Enzo Biochem
5.13.1 Enzo Biochem Profile
5.13.2 Enzo Biochem Main Business
5.13.3 Enzo Biochem POC Infectious Diseases Products, Services and Solutions
5.13.4 Enzo Biochem POC Infectious Diseases Revenue (US$ Million) & (2018-2023)
5.13.5 Enzo Biochem Recent Developments
6 North America
6.1 North America POC Infectious Diseases Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe POC Infectious Diseases Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific POC Infectious Diseases Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America POC Infectious Diseases Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa POC Infectious Diseases Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 POC Infectious Diseases Market Dynamics
11.1 POC Infectious Diseases Industry Trends
11.2 POC Infectious Diseases Market Drivers
11.3 POC Infectious Diseases Market Challenges
11.4 POC Infectious Diseases Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List